The review is the latest in an increasingly crowded portfolio of studies about e-cigs — none of which has been declared as the definitive public-health study on the products. On July 28, FDA ...

Achieve Life Sciences shares jumped after the company said it got a priority voucher for its treatment of nicotine dependence stemming from e-cigarettes and vaping. The stock was up by about one-third ...